Authors
Loading...
Gene expression shifts linked to cancer prognosis in various subtypes, suggesting PTPN1 as a potential biomarker.
Raval et al. (2025) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: